Johnson & Johnson (JNJ.N) rose 1.5% in premarket trading after the healthcare conglomerate beat Wall Street expectations for third-quarter sales, helped by strong demand for its cancer drug Darzalex and Crohn's disease drug Stelara. read moreGoldman Sachs Group Inc (GS.N) gained 0.9%, while Netflix (NFLX.O) added 1.6% ahead of earnings later in the day. read moreThe reversal of parts of a controversial UK fiscal plan that had roiled bond markets also aided sentiment. read more"Initial Q3 company reports have been positive, and you've had some stabilization in the United Kingdom with its government. ET, Dow e-minis were up 340 points, or 1.12%, S&P 500 e-minis were up 50.25 points, or 1.36%, and Nasdaq 100 e-minis were up 179.75 points, or 1.62%.

---